Daniel Davis
Director of Finance/CFO bei MONTEREY CAPITAL ACQUISITION CORPORATION
Profil
Daniel Davis is the founder of AngioWave Imaging, LLC.
He is currently the Chief Financial Officer at Connectm Technology Solutions, Inc. and Monterey Capital Acquisition Corp.
Previously, he served as the Chief Executive Officer at Change Dynamics LLC, Director-Life Sciences & Technology at Bourdon Associates, Inc., and Chief Financial Officer & VP-Business Development at Biopure Corp.
He also held the position of Chief Financial Officer at Sequre Dx, Inc. from 2021 to 2022.
Mr. Davis completed his undergraduate degree at Brown University and earned an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Daniel Davis
Unternehmen | Position | Beginn |
---|---|---|
MONTEREY CAPITAL ACQUISITION CORPORATION | Director of Finance/CFO | 01.04.2021 |
AngioWave Imaging, LLC | Founder | - |
Ehemalige bekannte Positionen von Daniel Davis
Unternehmen | Position | Ende |
---|---|---|
Sequre Dx, Inc.
Sequre Dx, Inc. Medical/Nursing ServicesHealth Services Sequre Dx, Inc. is a genomics intelligence company that focuses on advancing on-target gene editing and cell therapies from discovery to patient. The company is based in Waltham, MA. The company offers preclinical platforms for the biopharma industry, including diagnostic assays and bioinformatic analytics that solve preclinical off-target evaluation needs. Sequre Dx aims to make gene editing and cell therapies suitable for all patients who would benefit from these life-saving technologies. The CEO of the company is Ellen E. Sheets. | Director of Finance/CFO | 01.11.2022 |
Bourdon Associates, Inc.
Bourdon Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Bourdon Associates, Inc. performs financial and accounting services. The firm specializes in accounting and finance consulting, part time finance staff, outsourced controllers and senior accountants, interim staffing for senior finance roles, nonprofit and endowment accounting, audit preparation, and financial systems implementation. The company was founded by Jim Bourdon in 1998 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01.04.2020 |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Change Dynamics LLC
Change Dynamics LLC Packaged SoftwareTechnology Services Change Dynamics LLC designs and develops software solutions. The company was founded in August 2004 and is headquartered in Cedar Knolls, NJ. | President | - |
Ausbildung von Daniel Davis
Brown University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MONTEREY CAPITAL ACQUISITION CORPORATION | Finance |
Private Unternehmen | 5 |
---|---|
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
Bourdon Associates, Inc.
Bourdon Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Bourdon Associates, Inc. performs financial and accounting services. The firm specializes in accounting and finance consulting, part time finance staff, outsourced controllers and senior accountants, interim staffing for senior finance roles, nonprofit and endowment accounting, audit preparation, and financial systems implementation. The company was founded by Jim Bourdon in 1998 and is headquartered in Waltham, MA. | Commercial Services |
Change Dynamics LLC
Change Dynamics LLC Packaged SoftwareTechnology Services Change Dynamics LLC designs and develops software solutions. The company was founded in August 2004 and is headquartered in Cedar Knolls, NJ. | Technology Services |
Sequre Dx, Inc.
Sequre Dx, Inc. Medical/Nursing ServicesHealth Services Sequre Dx, Inc. is a genomics intelligence company that focuses on advancing on-target gene editing and cell therapies from discovery to patient. The company is based in Waltham, MA. The company offers preclinical platforms for the biopharma industry, including diagnostic assays and bioinformatic analytics that solve preclinical off-target evaluation needs. Sequre Dx aims to make gene editing and cell therapies suitable for all patients who would benefit from these life-saving technologies. The CEO of the company is Ellen E. Sheets. | Health Services |
AngioWave Imaging, LLC |